Omnio, a Umeå-based BioTech startup, has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds toward clinical…
Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds
What they do:
Clinically-validated ingredients from natural microbes
Quick facts:
HQ: New York, NY, United States
What they do:
Enabling next generation medicines. A comprehensive platform and…
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Maximum information per experiment, minimum experiments per conclusion
Quick facts:
HQ: Lund, Sweden
What they do:
Tech-powered women's wellness.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Decarbonizing the chemicals industry.
Quick facts:
HQ: Houston, TX, United States
What they do:
Unleash the potential of genomic medicine using AI
Quick facts:
Funding:
€23.2M · Series B · Oct 2026
Omnio, a Umeå-based BioTech startup, has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds toward clinical…
Sweden
Latest round: €2.9M (Oct 2026).
Similar startups: Kingdom, 64x Bio, and Halmos Labs.